WASHINGTON (AP) — The Food and Drug Administration says its ongoing safety review of the nation's main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug's use curtailed. The FDA gave a court-ordered update on its progress in a legal filing late Wednesday, [...]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | FDA says its safety review of abortion pill will continue into next year | 0 | 5.97 | 08-10-2026 |
| 2 | FDA says its safety review of abortion pill will continue into next year | 0 | 5.97 | 08-10-2026 |
| 3 | An appeals court is considering a push to restrict most common abortion method | 0 | 5.41 | 09-09-2026 |
| 4 | Abortion pill survivors urge Trump admin to stop defending Biden FDA policy | -8 | 4 | 09-07-2026 |
| 5 | Abtreibung in den USA: Oberstes Gericht erlaubt Postversand von Pillen vorerst weiter | 0 | 12.04 | 12-05-2026 |
| 6 | Todd Blanche Suggests He Is Open to Using the DOJ to Restrict Mailing the Abortion Pill | 0 | 4.88 | 17-07-2026 |
| 7 | Zydus Lifesciences gets USFDA nod for menopause treatment drug | 0 | 12.34 | 21-10-2026 |
| 8 | America's largest medical authority to launch 'safety' review of Covid and flu vaccines | 0 | 4.24 | 13-02-2026 |
| 9 | FDA orders Eli Lilly and Novo Nordisk to remove suicide warnings from Wegovy and Zepbound | 0 | 7.76 | 15-01-2026 |